SAT-LB080 Peptide Receptor Radionuclide Therapy in Metastatic Pheochromocytoma and Paraganglioma: The Putrajaya Experience

BACKGROUND: Most metastatic pheochromocytoma (PCC) and paraganglioma (PGL) express somatostatin receptors (SSTR) similar to neuroendocrine tumors, which may benefit from peptide radionuclide receptor therapy (PRRT), a molecular targeted therapy to SSTR avid tumors. We describe 5 cases of progressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Hui, Ezamshah, Arianne, Nasruddin, Azraai Bahari, Mohamad, Masni, Md Noor, Nurain, Lee, Boon Nang, Hussein, Zanariah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552363/
http://dx.doi.org/10.1210/js.2019-SAT-LB080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552363/
http://dx.doi.org/10.1210/js.2019-SAT-LB080

Ejemplares similares